In recent years, the major oncogenic pathways have been elucidated that drive tumor initiation and progression in NMTC, which mainly comprise the RAS-RAF-MEK-ERK and PI3K-AKT-mTOR signaling pathways (6, 35). Here, MAP2K7 is linked to neoplasm.